Prevention Strategies for Adolescents at Risk of Diabetes

NCT02545140 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 634

Last updated 2019-01-15

No results posted yet for this study

Summary

The primary aim of PRE-STARt Phase 1 is to pragmatically evaluate and refine a risk assessment tool to identify those children with chronic disease risk factors (including Type 2 Diabetes).

Conditions

Interventions

OTHER

No intervention

Sponsors & Collaborators

  • University of Leicester

    collaborator OTHER
  • Associacao Protectora dos Diabeticos de Portugal

    collaborator OTHER
  • The Algarve Regional Health Administration

    collaborator OTHER
  • University of Leipzig

    collaborator OTHER
  • Technische Universität Dresden

    collaborator OTHER
  • Alexander Technological Educational Institute, Thessaloniki, Greece

    collaborator OTHER
  • Diabetes Centre of Paediatrics P&A

    collaborator UNKNOWN
  • Athens General Children's Hospital "Pan. & Aglaia Kyriakou"

    collaborator OTHER
  • Primary Care Centre Egia, San Sebastian, Spain

    collaborator UNKNOWN
  • Basque Government Department of Public Health

    collaborator OTHER
  • Health Department of the Alto/Bajo Deba

    collaborator OTHER
  • University Hospitals, Leicester

    lead OTHER

Principal Investigators

  • Melanie J Davies, MD · University Hospitals, Leicester

Eligibility

Min Age
12 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02545140 on ClinicalTrials.gov